Genmab AS (Denmark) Price on April 11, 2024
| GMAB Stock | DKK 1,970 15.50 0.79% |
If you're considering investing in Genmab Stock, it is important to understand the factors that can impact its price. As of today, the current price of Genmab AS stands at 1,970, as last reported on the 30th of April, with the highest price reaching 2,003 and the lowest price hitting 1,946 during the day. We consider Genmab AS very steady. Genmab AS holds Efficiency (Sharpe) Ratio of 0.031, which attests that the entity had a 0.031% return per unit of risk over the last 3 months. We have found thirty technical indicators for Genmab AS, which you can use to evaluate the volatility of the firm. Please check out Genmab AS's Market Risk Adjusted Performance of (0.07), risk adjusted performance of 0.0263, and Downside Deviation of 1.72 to validate if the risk estimate we provide is consistent with the expected return of 0.059%.
Genmab Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Genmab |
Sharpe Ratio = 0.031
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | GMAB | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.9 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Genmab AS is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genmab AS by adding it to a well-diversified portfolio.
Genmab AS Valuation on April 11, 2024
It is possible to determine the worth of Genmab AS on a given historical date. On April 11, 2024 Genmab was worth 2090.0 at the beginning of the trading date compared to the closed value of 2063.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genmab AS stock. Still, in general, we apply an absolute valuation method to find Genmab AS's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genmab AS where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genmab AS's related companies.
| Open | High | Low | Close | Volume | |
| 2,055 | 2,094 | 2,014 | 2,086 | 108,543 | |
04/11/2024 | 2,090 | 2,106 | 2,044 | 2,063 | 110,088 |
| 2,063 | 2,122 | 2,063 | 2,067 | 68,505 |
| Backtest Genmab AS | | | Genmab AS History | | | Genmab AS Valuation | Previous | Next |
Genmab AS Trading Date Momentum on April 11, 2024
| On April 12 2024 Genmab AS was traded for 2,067 at the closing time. The highest price during the trading period was 2,122 and the lowest recorded bid was listed for 2,063 . The volume for the day was 68.5 K. This history from April 12, 2024 contributed to the next trading day price boost. The overall trading delta to the next closing price was 0.19% . The overall trading delta to the current price is 2.23% . |
Genmab AS Fundamentals Correlations and Trends
By evaluating Genmab AS's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genmab AS's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genmab financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Genmab AS Stock history
Genmab AS investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genmab is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genmab AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genmab AS stock prices may prove useful in developing a viable investing in Genmab AS
Genmab AS develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. Genmab AS was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab AS is traded on Copenhagen Stock Exchange in Denmark.
Genmab AS Stock Technical Analysis
Genmab AS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Genmab AS Period Price Range
Low | April 11, 2024
| High |
2,090 | 2,063 |
Genmab AS April 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Genmab AS stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genmab AS shares will generate the highest return on investment. By undertsting and applying Genmab AS stock market strength indicators, traders can identify Genmab AS entry and exit signals to maximize returns
| Accumulation Distribution | 3240.96 | |||
| Daily Balance Of Power | (0.44) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 2075.0 | |||
| Day Typical Price | 2071.0 | |||
| Market Facilitation Index | 6.0E-4 | |||
| Price Action Indicator | (25.50) | |||
| Period Momentum Indicator | (93.00) | |||
| Relative Strength Index | 47.26 |
Genmab AS Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Genmab AS's price direction in advance. Along with the technical and fundamental analysis of Genmab Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genmab to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0263 | |||
| Jensen Alpha | 0.0942 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0.08) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Genmab Stock analysis
When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |